Pharmaceutical laboratory and equipment provider Sartoriushttp://www.sartorius.com, has acquired U.S.-based IntelliCyt Corporation, a manufacturer of novel cell screening platforms used in drug discovery. Through the acquisition, Sartorius expands its current lab portfolio into bio analytics, strengthening its offering for biopharma customers and academia. Sartorius purchased IntelliCyt for $90 million. The company focuses on pharma, biotech and academic customers, and achieved strong double-...